Dilt-CD (Diltiazem Hydrochloride) - Summary

DILT-CD SUMMARY

DILT-CD
(Diltiazem Hydrochloride Extended-Release Capsules, USP) (Once-a-day dosage) 120 mg, 180 mg, 240 mg and 300 mg

Diltiazem hydrochloride is a calcium ion influx inhibitor (slow channel blocker or calcium antagonist).

DILT-CD (Diltiazem Hydrochloride Extended-Release Capsules, USP) (Once-a-day dosage) are indicated for the treatment of hypertension. They may be used alone or in combination with other antihypertensive medications.

DILT-CD (Diltiazem Hydrochloride Extended-Release Capsules, USP) (Once-a-day dosage) are indicated for the management of chronic stable angina and angina due to coronary artery spasm.

DILT-CD NEWS HIGHLIGHTS

Published Studies Related to Dilt-CD (Diltiazem)

Interaction between renal function and microalbuminuria for cardiovascular risk in hypertension: the nordic diltiazem study. [2008.07]

Effect of diltiazem and metoprolol on left atrial appendix functions in patients with nonvalvular chronic atrial fibrillation. [2007.03]

Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring. [2006.10]

Effects of itraconazole and diltiazem on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein. [2006.05]

No gender-associated differences of cyclosporine pharmacokinetics in stable renal transplant patients treated with diltiazem. [2005.10]

more>>

Clinical Trials Related to Dilt-CD (Diltiazem)

Food Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg [Completed]

Fasting Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg [Completed]

Fasting Study of Verapamil HCl Extended-Release Capsules 300 mg to Verelan® PM Extended-Release Capsules 300 mg [Completed]

Fasting Applesauce Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg [Completed]

The Effect of Concomitant Administration of Erythromycin and Diltiazem on CYP3A Activity in Healthy Volunteers [Completed]

more>>